Skip to main content
Top
Published in: Diabetologia 7/2004

01-07-2004 | Comment

—to: Hales CN, Ozanne SE (2003) For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019

Authors: A. Plagemann, E. Rodekamp, T. Harder

Published in: Diabetologia | Issue 7/2004

Login to get access

Excerpt

To the Editor: In their recent For Debate article, Hales and Ozanne gave an impressive overview of the overwhelming body of data accumulated over the past decade that seems to indicate a causal relationship between low birthweight and later development of the metabolic syndrome X [1]. More specifically, they state that fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome X and renal failure. However, the authors do not take into account a fundamental concept that is critically related to the pathophysiology of the metabolic syndrome X and its possible relation to low birthweight: obesity is known to be the key feature of human metabolic syndrome X. This factor requires explicit consideration. From a public health perspective, overweight is recognised as the major cause of the dramatic increase in the prevalence of Type 2 diabetes, the metabolic syndrome X, and critical cardiovascular endpoints observed in recent years [2]. To our knowledge, however, no study currently exists that describes an independent association between low birthweight and obesity in later life. Only inconsistent data are available on the risk of obesity in later life in low birthweight subjects, as recently reviewed by Oken and Gillman [3]. From these epidemiological data, it cannot be concluded that low birthweight is an independent risk factor for obesity in later life. …
Literature
1.
go back to reference Hales CN, Ozanne SE (2003) For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019CrossRefPubMed Hales CN, Ozanne SE (2003) For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019CrossRefPubMed
2.
go back to reference Mokdad AH, Ford ES, Bowman BA et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRefPubMed Mokdad AH, Ford ES, Bowman BA et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRefPubMed
4.
go back to reference Dörner G, Plagemann A (1994) Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk. Horm Metab Res 26:213–221CrossRef Dörner G, Plagemann A (1994) Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk. Horm Metab Res 26:213–221CrossRef
5.
go back to reference Stettler N, Zemel BS, Kumanyika S, Stallings VA (2002) Infant weight gain and childhood overweight status in a multicenter, cohort study. Pediatrics 109:194–199CrossRefPubMed Stettler N, Zemel BS, Kumanyika S, Stallings VA (2002) Infant weight gain and childhood overweight status in a multicenter, cohort study. Pediatrics 109:194–199CrossRefPubMed
6.
go back to reference Dewey KG (1998) Growth characteristics of breast-fed compared to formula-fed infants. Biol Neonate 74:94–105CrossRefPubMed Dewey KG (1998) Growth characteristics of breast-fed compared to formula-fed infants. Biol Neonate 74:94–105CrossRefPubMed
7.
go back to reference Plagemann A, Harder T, Rake A et al. (1999) Perinatal increase of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome X-like alterations in adulthood of neonatally overfed rats. Brain Res 836:146–155CrossRefPubMed Plagemann A, Harder T, Rake A et al. (1999) Perinatal increase of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome X-like alterations in adulthood of neonatally overfed rats. Brain Res 836:146–155CrossRefPubMed
Metadata
Title
—to: Hales CN, Ozanne SE (2003) For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019
Authors
A. Plagemann
E. Rodekamp
T. Harder
Publication date
01-07-2004
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1446-z

Other articles of this Issue 7/2004

Diabetologia 7/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.